The initial AESQC IFA products are a selection of the most common ANA IFA patterns, and will be supplemented with rarer patterns, undiluted controls, and further tissue-specific offerings.
OAKLAND, Calif. and WENDELSHEIM, DE (PRWEB) March 06, 2019
AESKU.GROUP – a science-focused manufacturer of autoimmune, allergy, food intolerance, and infectious disease diagnostics and automation – is pleased to announce its line of ICAP compatible IFA quality control (QC) products is now CE marked and FDA registered. The controls are designed to produce specific positive autoantibody patterns to help laboratories identify, correct, and prevent analytical failure prior to releasing IFA (also called IFT or immunofluorescence test) results.
The initial AESQC IFA products are a selection of the most common ANA IFA patterns, and will be supplemented with rarer patterns, undiluted controls, and further tissue-specific offerings. Lot-specific reference images of every AESQC IFA product and additional technical documentation are available at AESQC.com, the online QC resource from AESKU.GROUP.
AESKU.GROUP is headquartered in Wendelsheim, Germany and is made up of the following divisions: AESKU.DIAGNOSTICS, AESKU.THERAPY (Autoimmune Therapies), AESKU.SYSTEMS (Lab Automation), AESKU.INC (N. American headquarters in Oakland, CA), AESKU.NY (IFA Manufacturing and Research in Buffalo, NY), DST (Allergy Center of Excellence).
Besides its own outstanding commitment to research and development, AESKU.GROUP initiated and supports the AESKU.KIPP INSTITUTE, an independent non-profit organization, primarily active in basic research and interdisciplinary knowledge transfer in autoimmunity.